EC: 1.1.1.34
hydroxymethylglutaryl-CoA reductase (NADPH) ((R)-mevalonate:NADP+ oxidoreductase (CoA-acylating))
Pathways
| pathway id | name |
|---|---|
| BioCyc:META_PWY-922 | mevalonate pathway I |
| BioCyc:MOUSE_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:HUMAN_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:HUMAN_PWY-5910 | superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) |
| BioCyc:YEAST_ERGOSTEROL-SYN-PWY | superpathway of ergosterol biosynthesis |
| BioCyc:YEAST_PWY-5910 | superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) |
| BioCyc:YEAST_PWY-922 | mevalonate pathway |
| BioCyc:ARA_PWY-922 | mevalonate pathway I |
| BioCyc:META_PWY-5910 | superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) |
| BioCyc:META_PWY-6174 | mevalonate pathway II (archaea) |
| BioCyc:HUMAN_PWY-922 | mevalonate pathway |
| BioCyc:META_ERGOSTEROL-SYN-PWY | superpathway of ergosterol biosynthesis I |
| BioCyc:META_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:MOUSE_PWY-922 | mevalonate pathway I |
| PlantCyc:ARA_PWY-5910 | superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) |
| PlantCyc:PLANT_PWY-922 | mevalonate pathway I |
| PlantCyc:PLANT_PWY-5910 | superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) |
| PlantCyc:ARA_PWY-922 | mevalonate pathway I |
| Reactome:R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination |
| Reactome:R-HSA-9675108 | Nervous system development |
| Reactome:R-DME-9969896 | Lanosterol biosynthesis |
| Reactome:R-MMU-9969896 | Lanosterol biosynthesis |
| Reactome:R-SPO-9969896 | Lanosterol biosynthesis |
| Reactome:R-BTA-9969896 | Lanosterol biosynthesis |
| Reactome:R-DDI-9969896 | Lanosterol biosynthesis |
| Reactome:R-RNO-9969896 | Lanosterol biosynthesis |
| Reactome:R-SCE-9969896 | Lanosterol biosynthesis |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-556833 | Metabolism of lipids |
| Reactome:R-BTA-191273 | Cholesterol biosynthesis |
| Reactome:R-DDI-191273 | Cholesterol biosynthesis |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-8957322 | Metabolism of steroids |
| Reactome:R-SCE-8957322 | Metabolism of steroids |
| Reactome:R-SPO-1430728 | Metabolism |
| Reactome:R-BTA-8957322 | Metabolism of steroids |
| Reactome:R-DDI-8957322 | Metabolism of steroids |
| Reactome:R-DME-1430728 | Metabolism |
| Reactome:R-HSA-1266738 | Developmental Biology |
| Reactome:R-SCE-1430728 | Metabolism |
| Reactome:R-DME-8957322 | Metabolism of steroids |
| Reactome:R-MMU-191273 | Cholesterol biosynthesis |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-8957322 | Metabolism of steroids |
| Reactome:R-SCE-556833 | Metabolism of lipids |
| Reactome:R-SCE-191273 | Cholesterol biosynthesis |
| Reactome:R-SPO-8957322 | Metabolism of steroids |
| Reactome:R-DDI-1430728 | Metabolism |
| Reactome:R-DDI-556833 | Metabolism of lipids |
| Reactome:R-DME-556833 | Metabolism of lipids |
| Reactome:R-DME-191273 | Cholesterol biosynthesis |
| Reactome:R-RNO-191273 | Cholesterol biosynthesis |
| Reactome:R-SPO-556833 | Metabolism of lipids |
| Reactome:R-SPO-191273 | Cholesterol biosynthesis |
| WikiPathways:WP4189 | Mevalonate arm of cholesterol biosynthesis pathway with inhibitors |
| WikiPathways:WP5220 | Metabolic reprogramming in pancreatic cancer |
| WikiPathways:WP4190 | Mevalonate arm of cholesterol biosynthesis pathway |
| PathBank:SMP0000023 | Steroid Biosynthesis |
| PathBank:SMP0000387 | CHILD Syndrome |
| PathBank:SMP0000112 | Risedronate Action Pathway |
| PathBank:SMP0000508 | Cholesteryl Ester Storage Disease |
| PathBank:SMP0002438 | Cholesterol Biosynthesis and Metabolism CE(12:0) |
| PathBank:SMP0121055 | Mevalonate Pathway |
| PathBank:SMP0000389 | Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0000319 | Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0000082 | Simvastatin Action Pathway |
| PathBank:SMP0000111 | Cerivastatin Action Pathway |
| PathBank:SMP0000131 | Atorvastatin Action Pathway |
| PathBank:SMP0000511 | Wolman Disease |
| PathBank:SMP0002381 | Steroid Biosynthesis |
| PathBank:SMP0002436 | Cholesterol biosynthesis and metabolism CE(10:0) |
| PathBank:SMP0002441 | Cholesterol biosynthesis and metabolism CE(18:0) |
| PathBank:SMP0070041 | Cholesterol Biosynthesis and Metabolism |
| PathBank:SMP0000386 | Desmosterolosis |
| PathBank:SMP0000089 | Pravastatin Action Pathway |
| PathBank:SMP0000095 | Alendronate Action Pathway |
| PathBank:SMP0000099 | Lovastatin Action Pathway |
| PathBank:SMP0000117 | Pamidronate Action Pathway |
| PathBank:SMP0000509 | Hyper-IgD Syndrome |
| PathBank:SMP0121209 | Mevalonate Pathway |
| PathBank:SMP0000388 | Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0000079 | Ibandronate Action Pathway |
| PathBank:SMP0000092 | Rosuvastatin Action Pathway |
| PathBank:SMP0000209 | Hypercholesterolemia |
| PathBank:SMP0000107 | Zoledronate Action Pathway |
| PathBank:SMP0000119 | Fluvastatin Action Pathway |
| PathBank:SMP0000510 | Mevalonic Aciduria |
| PathBank:SMP0002384 | Terpenoid Backbone Biosynthesis |
| PathBank:SMP0002435 | Cholesterol biosynthesis and metabolism CE(14:0) |
| PathBank:SMP0002440 | Cholesterol Biosynthesis and Metabolism CE(16:0) |